Polyphenol‐Nanoengineered Monocyte Biohybrids for Targeted Cardiac Repair and Immunomodulation
Jiawen Li,Guidong Gong,Yue Zhang,Yanjiang Zheng,Yunxiang He,Mei Chen,Xianglian He,Xiaolan Zheng,Xue Gong,Lei Liu,Kaiyu Zhou,Zongmin Zhao,C. Wyatt Shields IV,Yimin Hua,Yifei Li,Junling Guo
DOI: https://doi.org/10.1002/adhm.202403595
IF: 10
2024-11-13
Advanced Healthcare Materials
Abstract:This work introduces a cell‐based heart‐specific immunotherapy for myocardial infarction, based on the engineering of a monocyte nanobiohybrid system through polyphenol‐mediated interfacial assembly of interleukin‐10 and microRNA‐19a on the cell surface. This strategy facilitates macrophage immunomodulation toward reparative roles and stimulates cardiac repair, significantly enhancing heart function and offering a novel nanotherapeutic approach for cardiovascular diseases. Myocardial infarction is one of the leading cause of cardiovascular death worldwide. Invasive interventional procedures and medications are applied to attenuate the attacks associated with ischemic heart disease by reestablishing blood flow and restoring oxygen supply. However, the overactivation of inflammatory responses and unsatisfactory drug delivery efficiency in the infarcted regions prohibit functional improvement. Here, a nanoengineered monocyte (MO)‐based biohybrid system, referred to as CTAs @MOs, for the heart‐targeted delivery of combinational therapeutic agents (CTAs) containing anti‐inflammatory IL‐10 and cardiomyogenic miR‐19a to overcome the limitation of malperfusion within the infarcted myocardium through a polyphenol‐mediated interfacial assembly, is reported. Systemic administration of CTAs@MOs bypasses extensive thoracotomy and intramyocardial administration risks, leading to infarcted heart‐specific accumulation and sustained release of therapeutic agents, enabling immunomodulation of the proinflammatory microenvironment and promoting cardiomyocyte proliferation in sequence. Moreover, CTAs@MOs, which serve as a cellular biohybrid‐based therapy, significantly improve cardiac function as evidenced by enhanced ejection fractions, increased fractional shortening, and diminished infarct sizes. This polyphenol nanoengineered biohybrid system represents a general and potent platform for the efficient treatment of cardiovascular disorders.
nanoscience & nanotechnology,engineering, biomedical,materials science, biomaterials